← Aurinia Pharmaceuticals Inc.
| Annual Trend | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $173k |
$420k
+142.77%
|
$463k
+10.24%
|
$318k
-31.32%
|
$50.1m
+15660.38%
|
$45.6m
-9.00%
|
$134.0m
+193.89%
|
$175.5m
+30.95%
|
$235.1m
+33.97%
|
$283.1m
+20.38%
|
$311.5m
+10.05%
|
|
| Revenue From Interest | $27k | $1.0m | $2.2m | $2.7m | — | — | — | — | — | — | — | |
| Cost of Goods and Services Sold | — | — | — | $0 | $0 | $1.1m |
$5.7m
+419.16%
|
$14.1m
+149.79%
|
$28.2m
+99.66%
|
$32.7m
+15.64%
|
$30.0m
-8.05%
|
|
| Gross Profit (Calculated) | — | — | — | $318k |
$50.1m
+15660.38%
|
$44.5m
-11.18%
|
$128.4m
+188.37%
|
$161.4m
+25.71%
|
$206.9m
+28.21%
|
$250.4m
+21.03%
|
— | |
| Research and Development Expense | $14.5m | $33.9m | $41.4m | $52.9m | $50.3m | $51.1m | $45.0m | $49.6m | $20.8m | $32.5m | $39.9m | |
| Selling, General and Administrative Expense | — | — | — | — | — | $171.4m | $196.4m | $195.0m | — | — | $101.0m | |
| Amortization of Intangible Assets | $1.5m | $1.4m | $1.5m | $1.4m | $1.3m | $2.1m | $2.1m | $1.7m | $900k | $800k | — | |
| Restructuring Costs | — | — | — | — | — | — | — | — | $23.1m | $1.6m | — | |
| Operating Expenses | — | — | — | — | $154.4m | — | — | — | $239.8m | $178.1m | $160.8m | |
| Other Operating Income Expense | ($2.2m) | $195k | $2.1m | ($9.0m) | — | — | — | — | — | — | — | |
| Operating Income (Loss) | ($25.0m) |
($46.9m)
-87.27%
|
($54.1m)
-15.42%
|
($85.2m)
-57.58%
|
($104.3m) | ($180.7m) | ($111.5m) | ($91.7m) | ($4.7m) | $104.9m |
$150.7m
+43.69%
|
|
| Other Operating Income (Expense), Net | — | — | — | — | $6.8m | ($574k) | $1.5m | ($8.4m) | $4.3m | ($9.5m) | — | |
| Interest Expense | — | — | — | $39k | — | — | — | $2.8m | — | — | $4.1m | |
| Interest Income, Other | — | — | — | — | $1.5m | $529k | — | — | — | — | $13.7m | |
| Interest Expense (non-operating) | — | — | — | — | — | — | — | — | $4.8m | $4.3m | $4.1m | |
| Interest Income (Expense), Nonoperating, Net | — | — | — | — | — | — | $5.1m | $17.0m | — | — | $13.7m | |
| Income (Loss) from Continuing Operations before Income Taxes, Domestic | $25.0m | $46.9m | $54.1m | $85.2m | ($61.0m) | ($180.4m) | ($112.4m) | ($90.2m) | ($8.4m) | $103.9m | $160.4m | |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | $25.0m | $46.9m | $54.1m | $85.2m | ($102.8m) | ($180.2m) | ($106.4m) | ($77.5m) | $7.4m | $114.2m | $160.4m | |
| Income Tax Expense (Benefit) | $0 | $0 | $73k | $144k | ($94k) | $760k | $1.8m | $551k | $1.7m | ($173.0m) | ($153.8m) | |
| Net Income (Loss) Attributable to Parent | ($25.0m) |
($46.9m)
-87.27%
|
($64.0m)
-36.65%
|
($123.7m)
-93.14%
|
($102.7m)
+16.99%
|
($181.0m)
-76.24%
|
($108.2m)
+40.22%
|
($78.0m)
+27.88%
|
$5.8m
+107.37%
|
$287.2m
+4893.08%
|
$314.1m
+9.37%
|
|
| Earnings Per Share, Basic | ($0.66) | ($0.92) | ($0.76) | ($1.33) | — | ($1.40) | ($0.76) | ($0.54) | $0.04 | $2.14 | $2.36 | |
| Earnings Per Share, Diluted | ($0.66) | ($0.92) | ($0.76) | ($1.33) | — | ($1.40) | ($0.76) | ($0.54) | $0.04 | $2.07 | $2.28 | |
| Weighted Average Number of Shares Outstanding, Basic | — | — | — | — | — | — | 141.9m | 143.2m | 143.1m | 134.4m | 131.5m | |
| Weighted Average Number of Shares Outstanding, Diluted | — | — | — | — | — | — | 141.9m | 143.2m | 146.2m | 138.7m | 136.4m | |
| Additional Financial Items | ||||||||||||
| Costs and Expenses | — | — | — | — | — | $226.3m | $245.5m | $267.2m | $239.8m | $178.1m | — | |
| Depreciation Right of Use Assets | — | — | — | $124k | — | — | — | — | — | — | — | |
| Expense From Share-Based Payment Transactions With Employees | — | $4.2m | $6.9m | $7.4m | — | — | — | — | — | — | — | |
| Expense Relating To Short-Term Leases For Which Recognition Exemption Has Been Used | — | — | — | $67k | — | — | — | — | — | — | — | |
| Expense Relating To Variable Lease Payments Not Included In Measurement Of Lease Liabilities | — | — | — | $79k | — | — | — | — | — | — | — | |
| Finance Income | $27k | $702k | $2.2m | — | — | — | — | — | — | — | — | |
| Professional Fees Expense | $1.7m | $2.1m | $4.2m | $4.7m | — | — | — | — | — | — | — | |
| Profit Loss Before Tax | — | — | ($64.0m) | ($123.7m) | — | — | — | — | — | — | — | |
| Profit Loss From Operating Activities | ($25.0m) | ($46.9m) | ($54.1m) | ($85.2m) | ($104.3m) | ($180.7m) | ($111.5m) | ($91.7m) | ($4.7m) | $104.9m | — |